SCHEMBL25540241

SCHEMBL25540241

CC1(C)c2cccc(-c3ccc(-c4ccc(-c5nc(-c6ccccc6)cc(-c6ccccc6-c6ccccc6)n5)c5ccccc45)c4ccccc34)c2-c2ccc3ccccc3c21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.35
KDM4E B2RXH2 3/20 0.35
ALDH1A1 P00352 3/20 0.35
HPGD P15428 3/20 0.35
ACACA Q13085 1/20 0.32
ENPP3 O14638 1/20 0.32
ENPP1 P22413 1/20 0.32
MEN1 O00255 5/20 0.32
KMT2A Q03164 5/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
TDP1 Q9NUW8 3/20 0.32
LMNA P02545 2/20 0.32
TSHR P16473 2/20 0.32
ATM Q13315 2/20 0.32
TP53 P04637 1/20 0.32
NFKB1 P19838 1/20 0.32
MAPK1 P28482 1/20 0.32
NFKB2 Q00653 1/20 0.32
RELA Q04206 1/20 0.32
HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25539080 1.00 MAPT (0.35) MAPTKDM4EALDH1A1HPGDACACA
SCHEMBL25539100 0.98 ALDH1A1 (0.34) MAPTKDM4EALDH1A1HPGDACACA
SCHEMBL25540414 0.98 ALDH1A1 (0.34) MAPTKDM4EALDH1A1HPGDACACA
SCHEMBL25539090 0.96 MAPT (0.34) MAPTKDM4EALDH1A1HPGDENPP3
SCHEMBL25538291 0.96 MEN1 (0.34) MAPTKDM4EALDH1A1HPGDENPP3
SCHEMBL25540419 0.96 MEN1 (0.34) MAPTKDM4EALDH1A1HPGDENPP3
SCHEMBL25540237 0.96 HPGD (0.35) MAPTKDM4EALDH1A1HPGDACACA
SCHEMBL25539074 0.96 HPGD (0.35) MAPTKDM4EALDH1A1HPGDACACA
SCHEMBL25539111 0.95 KDM4E (0.33) MAPTKDM4EALDH1A1HPGDACACA
SCHEMBL25539086 0.94 MEN1 (0.35) MAPTKDM4EALDH1A1HPGDENPP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM MAPT 1595/4885KDM4E 1565/4885ALDH1A1 254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.